Schlagwort: Cancer
Can biopharma’s drug-focused R&D strategy remain profitable?
Since the 1990s, there has been a shift in focus within pharmaceutical R&D. It resulted in placing greater emphasis on areas such as cancer,...
A trimmed biotech basket
Following a strong performance in the summer period, shares of German biotech companies were affected by another global downward trend. We have adjusted the...
Advanced Therapies: Personalisierte medizinische Behandlung
Neuartige Therapien, sogenannte Advanced Therapies, stellen einen hochmodernen Bereich in der Medizin dar und bieten das Potenzial für innovative und transformative Lösungen bei der...
Defence Therapeutics Inc.: Will there soon be a vaccination against cancer?
Defence Therapeutics Inc. ("DTC") is a Canadian biotech company specialising in the development of vaccines and the improved transport of active substances into diseased...
Affimed präsentiert neue AFM13-Daten
Diese Nachricht basiert auf einer Pressemitteilung von Affimed N.V.
Affimed N.V. (Nasdaq: AFMD) präsentierte heute auf einem Poster, das auf der Jahrestagung der American Association...